+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years - 55Years
All Genders
Healthy Volunteers
ID07789899

Evaluation of Pharmacokinetics, Safety, and Tolerability of Two GSK3862995B Formulations in Healthy Adults After a Single Dose

Led by GlaxoSmithKline · Updated on 2026-09-01

24

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating two different formulations of the investigational medicine GSK3862995B in healthy adults. The study aims to understand how the body absorbs and processes each formulation, while also assessing their safety and tolerability. This phase 1 trial is sponsored by GlaxoSmithKline and focuses on healthy participants aged 18 to 55 years. Participants will be randomly assigned to receive either GSK3862995B Formulation A or Formulation B. Each participant will receive a single dose of the assigned formulation. The study does not use blinding, and the two groups run in parallel to compare the pharmacokinetics and safety of each formulation over time. During the study, participants will undergo medical evaluations including laboratory tests, cardiac monitoring, and physical exams. The primary outcomes measured include the drug concentration in the blood over time, maximum blood concentration, and any adverse events or changes in laboratory parameters, vital signs, and ECG findings. Safety will be monitored up to 49 weeks, with pharmacokinetic assessments continuing through 36 weeks. The total participation time covers this extended monitoring period.

CONDITIONS

Brief Title

A Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Two GSK3862995B Formulations in Healthy Participants

Research Team

U

US GSK Clinical Trials Call Center

E

EU GSK Clinical Trials Call Center

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here